Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer CenterTroy Z. Horvat, Paul B. Chapman, Michael A. Postow et al.|Journal of Clinical Oncology|2015Cited by 1.1k
Smoking History and Response to Nivolumab in Patients with Advanced NsclcsMatthew D. Hellmann, Naiyer A. Rizvi, Ben Creelan et al.|Annals of Oncology|2014Cited by 32